News

Search EMA's news announcements

Resultater (3800)

COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases

25 marts 2021

NewsHumanCOVID-19Vaccines

EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials

22 marts 2021

NewsHumanCOVID-19Medicines

Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021

19 marts 2021

NewsVeterinaryMedicines

COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets

19 marts 2021

NewsHumanCOVID-19Vaccines

Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues

16 marts 2021

NewsHumanCOVID-19Vaccines

EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update

15 marts 2021

NewsHumanCOVID-19Vaccines

EMA Management Board – highlights of March 2021 meeting

12 marts 2021

NewsCorporate

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021

12 marts 2021

NewsHumanCOVID-19PharmacovigilanceReferrals

Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion

12 marts 2021

NewsHumanPharmacovigilanceReferrals

COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update

11 marts 2021

NewsHumanCOVID-19Vaccines